Related by context. Frequent words. (Click for all words.) 74 Pivotal Phase III 72 Phase III Clinical Trial 71 Patient Enrollment 70 Fibrillex TM 69 Phase III Trial 69 FDA Accepts 69 Clinical Trial Results 69 Pivotal Phase 68 Completes Enrollment 68 Panzem R 68 Presents Positive 68 Pirfenidone 68 Pivotal Trial 68 refractory chronic lymphocytic 68 Kuvan R 68 Drug Candidate 67 teduglutide 67 Cetrorelix 67 Entereg R 67 RNAi Therapeutics 67 Initiate Phase 67 Single Dose 67 Metastatic Melanoma 67 FDA Orphan Drug 67 forodesine 66 Marketing Authorization Application 66 Preclinical Data 66 ThermoDox R 66 Golimumab 66 Mipomersen 66 alvimopan 66 PROMACTA 66 Amrubicin 65 Daclizumab 65 Initiates Phase 65 Cinryze TM 65 Pulmonary Arterial Hypertension 65 Argatroban 65 elotuzumab 65 Aloxi R 65 R bortezomib 65 Belimumab 65 Generic Version 65 PREOS 65 Phase Ib II 65 Epratuzumab 65 Restanza 65 II Clinical Trial 65 Transcept Pharmaceuticals 65 Ofatumumab 64 rilonacept 64 Traficet EN 64 R sorafenib tablets 64 Nexavar ® 64 methylnaltrexone 64 Dapagliflozin 64 Cethromycin 64 Onalta 64 Positive Opinion 64 Recombinant Human 64 6R BH4 64 Monotherapy 64 Icatibant 64 Metastatic Colorectal Cancer 64 KRN# 64 Small Molecule 64 MKC# 64 NASDAQ DYAX 64 KNS # 63 Voreloxin 63 phase IIb clinical 63 DDP# 63 Extended Release 63 pseudobulbar affect PBA 63 Microplasmin 63 Phase IIIb 63 Elesclomol 63 ZALBIN 63 Well Tolerated 63 Phenoptin 63 Benign Prostatic Hyperplasia 63 Gemzar ® 63 albinterferon alfa 2b 63 Idera Pharmaceuticals 63 Ixempra 63 Ferumoxytol 63 Diabetic Macular Edema 63 immuno inflammatory diseases 63 BLA submission 63 Patent Covering 63 Extended Release Tablets 63 ISTODAX 62 Inc Therapeutic Competitors 62 HCV protease inhibitor 62 Naproxcinod 62 PEG SN# 62 INCB# [001] 62 Cloretazine R VNP#M 62 Rebif ® 62 Marketing Authorization Application MAA 62 Advancing Drugs